Shenzhen BGI To Be Listed On Hong Kong Stock Market Led By Citigroup And Morgan Stanley
This article was originally published in PharmAsia News
Executive Summary
Shenzhen BGI intends to list on the Hong Kong stock market to raise as much as $400 million in an offer led by Citigroup and Morgan Stanley.